A security analysis is not yet prepared for this market.
The series is stated in the current share scale after splits; dividends are not included in the price
Pulse Biosciences, Inc (PLSE) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2026-06-30, revenue was 1.2m $, net income was -80.1m $. Incorporated in the United States.
This summary is compiled automatically from SEC filings and exchange data.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Pulse Biosciences, Inc (PLSE) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Pulse Biosciences, Inc (PLSE) on November 18, 2026 is $45.95, +2.48% on the day. Over 52 weeks the stock traded between $12.56 and $58.94; the price now sits 72% of the way up that range. Over the past year the price changed by +234.18%. Market capitalisation is $3.15 billion, rank 20 among 101 stocks of the same industry with a known capitalisation.
Pulse Biosciences, Inc trades on Nasdaq under the ticker PLSE. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks PLSE has traded between $12.56 and $58.94. As of 18 November 2026 the price stood 71.99% of the way from the 52-week low to the high.
Over one year PLSE shares rose 229.91%; over six months they rose 85.50%. Volatility over 90 days is 70.58%. Dividends are not included: this is price change only, as of 18 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 2,659, above the sector median of 3.5. Price to book is 31.7, above the sector median of 2.3. Calculated from reports for the period ending 30 June 2026.
Pulse Biosciences, Inc reported revenue of $1M and a net loss of $80M over the last four quarters. Net margin is −6,755.78%. Market capitalisation is $3.2B.
PLSE has a return on equity of −80.46%, below the sector median of −40.58%. Return on assets is −69.27%, below the sector median of −30.08%. Operating margin is −7,007.76%, below the sector median of −20.96%.